Drug: Bevacizumab Injury: Sepsis Quarter: 2016Q3
Total Records: 23 Number of Pages: 2
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 79979883 | Bevacizumab | Sepsis | ROCHE | 45.00 YR | F | 113 KG | 20160929 | US |
| 81331126 | Bevacizumab | Sepsis | ROCHE | 0.00 | F | 0 | 20160912 | US |
| 82373662 | Bevacizumab | Sepsis | ROCHE | 71.70 YR | M | 66 KG | 20160919 | US |
| 87204837 | Bevacizumab | Sepsis | ROCHE | 58.00 YR | F | 79 KG | 20160930 | US |
| 95804078 | Bevacizumab | Sepsis | ROCHE | 78.80 YR | M | 70 KG | 20160818 | GB |
| 98802802 | Bevacizumab | Sepsis | ROCHE | 51.16 YR | M | 66 KG | 20160726 | DE |
| 104009286 | Bevacizumab | Sepsis | ROCHE | 0.00 | 0 | 20160916 | DE | |
| 125300961 | Bevacizumab | Sepsis | CIPLA | 57.00 YR | M | 0 | 20160706 | FR |
| 125484302 | Bevacizumab | Sepsis | ROCHE | 83.00 YR | F | 70 KG | 20160916 | US |
| 125515301 | Bevacizumab | Sepsis | CIPLA | 0.00 | 0 | 20160713 | US | |
| 125515661 | Bevacizumab | Sepsis | CIPLA | 0.00 | 0 | 20160713 | US | |
| 125545601 | BEVACIZUMAB | Sepsis | BAUSCH AND LOMB | 69.00 YR | F | 0 | 20160713 | JP |
| 125653661 | Bevacizumab | Sepsis | CELGENE | 0.00 | 0 | 20160718 | US | |
| 125869671 | Bevacizumab | Sepsis | ROCHE | 76.00 YR | M | 0 | 20160725 | JP |
| 126128551 | Bevacizumab | Sepsis | ROCHE | 0.00 | 0 | 20160802 | US | |
| 126251631 | BEVACIZUMAB | Sepsis | JANSSEN | 0.00 | F | 0 | 20160805 | US |
| 126267892 | BEVACIZUMAB | Sepsis | AMGEN | 0.00 | F | 0 | 20160812 | US |
| 127192181 | Bevacizumab | Sepsis | ROCHE | 22.00 YR | M | 76 KG | 20160907 | JP |
| 127446291 | Bevacizumab | Sepsis | ROCHE | 21.00 YR | M | 55 KG | 20160915 | US |
| 127451461 | Bevacizumab | Sepsis | ROCHE | 76.00 YR | F | 61 KG | 20160915 | US |
Total Records: 23 Number of Pages: 2